retatrutide and type 1 diabetes π©Ί in 2 diabetes: TRANSCEND-T2D-1 Phase 3 results β HbA1c β2.0% + weight β16.8% at 40 weeks. A triple agonist that tackles both glycemia obesity simultaneously. ππ Ref: Lilly Reta for type 1 diabetic
Pay in 4 interest-free payments of $6.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28

























